Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3393 | 1178 | 26.3 | 42% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 357 | 31315 | CONTRACEPTION//EMERGENCY CONTRACEPTION//MEDICAL ABORTION |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 15931 | 615 | ETHINYLESTRADIOL//GESTODENE//CAS 57 63 6 |
| 27133 | 194 | CHOLESTERYL 14 METHYLHEXADECANOATE//SBU FC HT//HIGH CARDIAC OUTPUT STATE |
| 29131 | 157 | AVITRIPTAN//ENVIRONM INJURY EPIDEMIOL TOXICOL UNIT//HOMICIDE PREVENTION |
| 31057 | 128 | VISNAGIN//AMMI VISNAGA//FURANOCHROMONES |
| 33815 | 84 | P450 ENZYME//ENZYMELESS BIOSENSORS//IRON TETRAPYRIDINOPORPHYRAZINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | VISNAGIN | Author keyword | 21 | 71% | 1% | 17 |
| 2 | AMMI VISNAGA | Author keyword | 18 | 67% | 1% | 16 |
| 3 | FURANOCHROMONES | Author keyword | 4 | 67% | 0% | 4 |
| 4 | ETHINYLESTRADIOL | Author keyword | 4 | 10% | 3% | 33 |
| 5 | GESTODENE | Author keyword | 3 | 15% | 2% | 18 |
| 6 | CAS 57 63 6 | Author keyword | 3 | 60% | 0% | 3 |
| 7 | KHELLIN | Author keyword | 3 | 25% | 1% | 9 |
| 8 | ETHINYLOESTRADIOL | Author keyword | 2 | 28% | 1% | 7 |
| 9 | CRST BIOSTAT UNIT | Address | 2 | 67% | 0% | 2 |
| 10 | LEVO NORGESTREL | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | VISNAGIN | 21 | 71% | 1% | 17 | Search VISNAGIN | Search VISNAGIN |
| 2 | AMMI VISNAGA | 18 | 67% | 1% | 16 | Search AMMI+VISNAGA | Search AMMI+VISNAGA |
| 3 | FURANOCHROMONES | 4 | 67% | 0% | 4 | Search FURANOCHROMONES | Search FURANOCHROMONES |
| 4 | ETHINYLESTRADIOL | 4 | 10% | 3% | 33 | Search ETHINYLESTRADIOL | Search ETHINYLESTRADIOL |
| 5 | GESTODENE | 3 | 15% | 2% | 18 | Search GESTODENE | Search GESTODENE |
| 6 | CAS 57 63 6 | 3 | 60% | 0% | 3 | Search CAS+57+63+6 | Search CAS+57+63+6 |
| 7 | KHELLIN | 3 | 25% | 1% | 9 | Search KHELLIN | Search KHELLIN |
| 8 | ETHINYLOESTRADIOL | 2 | 28% | 1% | 7 | Search ETHINYLOESTRADIOL | Search ETHINYLOESTRADIOL |
| 9 | LEVO NORGESTREL | 2 | 67% | 0% | 2 | Search LEVO+NORGESTREL | Search LEVO+NORGESTREL |
| 10 | VISNADIN | 2 | 67% | 0% | 2 | Search VISNADIN | Search VISNADIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ETHYNYLESTRADIOL | 15 | 39% | 3% | 31 |
| 2 | WASH OUT PHASE | 14 | 100% | 1% | 7 |
| 3 | ETHINYLESTRADIOL | 11 | 16% | 5% | 64 |
| 4 | ORAL CONTRACEPTIVE STEROIDS | 9 | 27% | 2% | 29 |
| 5 | NORETHINDRONE | 7 | 25% | 2% | 25 |
| 6 | FURANOCHROMONES | 6 | 80% | 0% | 4 |
| 7 | GESTODENE | 6 | 20% | 2% | 25 |
| 8 | 12 CYCLES | 5 | 54% | 1% | 7 |
| 9 | 14 WOMEN | 4 | 75% | 0% | 3 |
| 10 | CONTRACEPTIVE STEROID DESOGESTREL | 4 | 75% | 0% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Drug interactions between oral contraceptives and antibiotics | 2001 | 75 | 35 | 94% |
| Gender Differences in Drug Bioequivalence: Time to Rethink Practices | 2013 | 4 | 5 | 80% |
| Oral contraceptive efficacy and antibiotic interaction: A myth debunked | 2002 | 40 | 33 | 82% |
| Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy | 1996 | 45 | 31 | 61% |
| PHARMACOKINETIC DRUG-INTERACTIONS WITH ORAL-CONTRACEPTIVES | 1990 | 138 | 66 | 64% |
| Pharmacokinetic drug interactions involving 17 alpha-ethinylestradiol - A new look at an old drug | 2007 | 53 | 170 | 35% |
| GENDER EFFECTS IN PHARMACOKINETICS AND PHARMACODYNAMICS | 1995 | 318 | 138 | 18% |
| Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill - A literature review | 1999 | 27 | 17 | 82% |
| Interactions between oral contraceptives and antifungals antibacterials - Is contraceptive failure the result? | 1999 | 15 | 20 | 100% |
| CLINICAL PHARMACOKINETICS OF ORAL-CONTRACEPTIVE STEROIDS | 1983 | 120 | 62 | 74% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CRST BIOSTAT UNIT | 2 | 67% | 0.2% | 2 |
| 2 | PHYTOCHEM ORGAN CHEM | 1 | 50% | 0.2% | 2 |
| 3 | SBU FC HT | 1 | 100% | 0.2% | 2 |
| 4 | CENT NY | 1 | 50% | 0.1% | 1 |
| 5 | ENVIRONM INJURY EPIDEMIOL TOXICOL UNIT | 1 | 50% | 0.1% | 1 |
| 6 | FARMACOL TOXICOL ENFERMERIA | 1 | 50% | 0.1% | 1 |
| 7 | INVEST FARMACOL TOXICOL | 1 | 50% | 0.1% | 1 |
| 8 | ONCOL PHYSIOL | 1 | 50% | 0.1% | 1 |
| 9 | ORGAN CHEM TAKATSU KU | 1 | 50% | 0.1% | 1 |
| 10 | PHARM INFECT DIS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000031828 | DOPING CONTROL//EPITESTOSTERONE//DOPING ANALYSIS |
| 2 | 0.0000027697 | CONTRACEPTION//EMERGENCY CONTRACEPTION//MEDICAL ABORTION |
| 3 | 0.0000017821 | 17 BETA AMINOESTROGENS//PROLAME//PENTOLAME |
| 4 | 0.0000014841 | 2 METHOXYESTRADIOL//INDOLE 3 CARBINOL//3 3 DIINDOLYLMETHANE |
| 5 | 0.0000011109 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR |
| 6 | 0.0000010403 | CAFFEINE//COFFEE//ENERGY DRINKS |
| 7 | 0.0000008739 | A MCKAY PLOT//TRITIUM NMR//ORTHO LABELLING |
| 8 | 0.0000008717 | PELVIC EXAMINATION//PELVIC EXAMINATIONS//GYNAECOLOGIC EXAMINATION |
| 9 | 0.0000007513 | STEROIDS//OSW 1//SQUALAMINE |
| 10 | 0.0000007505 | MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS |